Dexanabinol in Severe Traumatic Brain Injury
NCT00129857
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
860
Enrollment
INDUSTRY
Sponsor class
Conditions
Traumatic Brain Injury
Interventions
DRUG:
Dexanabinol
Sponsor
Pharmos